Sandbox/Alejandro: Difference between revisions

Jump to navigation Jump to search
Line 70: Line 70:
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Bullous Impetigo - Adults}}
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Bullous Impetigo - Adults}}
|-
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Preferred Regimen
 
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Mupirocin]] 2% apply to lesions q8h x 7 days'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Alternative Regimen
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Fusidic acid]] 2% apply to lesions q8h''''' <br> OR <br> ▸ '''''[[Retapamulin]] 1% apply to lesions q12h x 5 days'''''
|-
|-
|}
|}
Line 104: Line 98:
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Non-Bullous Impetigo - Adults}}
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Non-Bullous Impetigo - Adults}}
|-
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Preferred Regimen
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Topical Regimen
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸  
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Mupirocin]] 2% apply to lesions q8h x 7 days''''' <br> OR <br> ▸'''''[[Fusidic acid]] 2% apply to lesions q8h x 7 days''''' <br> OR <br> '''''[[Retapamulin]] 1% apply to lesions q12h x 5 days'''''|-
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Oral Regimen
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸  
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Alternative Regimen
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸

Revision as of 19:24, 29 May 2014

IMPETIGO

Medical Therapy

  • The treatment of impetigo depends on the location and number of lesions. Antibiotic therapy could be administered topically or orally.
  • Topical therapy is preferred for patients with small amount of lesions and without any bullae. [1]
  • Oral regimens are used for patients with several lesions and patients with bullous impetigo.
  • Non-medical therapy involves washing the lesions and the rest of the body with soap and water, and letting the impetigo dry in the air.
  • It is very important to remove the crusts before applying ointment, as the bacteria that cause the disease are located underneath them.


▸ Click on the following categories to expand treatment regimens.

Bullous Impetigo

  ▸  Adults

  ▸  Children

Non-Bullous Impetigo

  ▸  Adults

  ▸  Children

Bullous Impetigo - Adults
Bullous Impetigo - Children
Preferred Regimen
PLUS
Alternative Regimen
Non-Bullous Impetigo - Adults
Topical Regimen
Mupirocin 2% apply to lesions q8h x 7 days
OR
Fusidic acid 2% apply to lesions q8h x 7 days
OR
Retapamulin 1% apply to lesions q12h x 5 days|-
Oral Regimen
Non-Bullous Impetigo - Children
Preferred Regimen
PLUS
Alternative Regimen
  1. Sander Koning, Renske van der Sande, Arianne P. Verhagen, Lisette W. A. van Suijlekom-Smit, Andrew D. Morris, Christopher C. Butler, Marjolein Berger & Johannes C. van der Wouden (2012). "Interventions for impetigo". The Cochrane database of systematic reviews. 1: CD003261. doi:10.1002/14651858.CD003261.pub3. PMID 22258953.